无法登陆
无法注册账号
Description
本产品致力于帮助医院提升缺血性卒中疾病治疗的医疗质量，采用深度学习技术与临床知识相结合的方法，辅助医生进行脑梗死及颅内血管影像分析、缺血性卒中病因及发病机制辅助分析，提供基于指南推荐的缺血性卒中急性期管理及二级预防临床辅助决策。临床医生可在iCDSS软件的辅助下，结合患者的病史、症状以及相关诊断结果进行诊断及治疗。
Screenshots
iCDSS FAQ
-
Is iCDSS free?
Yes, iCDSS is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is iCDSS legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does iCDSS cost?
iCDSS is free.
-
What is iCDSS revenue?
To get estimated revenue of iCDSS app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Hong Kong SAR China yet.
Ratings History
iCDSS Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
iCDSS Installs
Last 30 days
iCDSS Revenue
Last 30 daysiCDSS Revenue and Downloads
Gain valuable insights into iCDSS performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Utilities
- Publisher
-
北京安德医智科技有限公司
- Languages
- Chinese
- Recent release
- 1.3.3 (2 years ago )
- Released on
- Apr 21, 2022 (2 years ago )
- Also available in
- China, Portugal, Kuwait, Kazakhstan, Lebanon, Mexico, Malaysia, Nigeria, Netherlands, Norway, New Zealand, Peru, Philippines, Pakistan, Poland, South Korea, Romania, Russia, Saudi Arabia, Sweden, Singapore, Thailand, Türkiye, Taiwan, Ukraine, United States, Vietnam, South Africa, Spain, Austria, Australia, Azerbaijan, Belgium, Belarus, Switzerland, Chile, Czechia, Germany, Denmark, Algeria, Egypt, United Arab Emirates, Finland, France, United Kingdom, Greece, Hong Kong SAR China, Hungary, Indonesia, Ireland, Israel, India, Italy, Japan
- Last Updated
- 3 weeks ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.